Prestaciones Bioquímicas que requieren Auditoría Médica
A continuación se detallan las prestaciones bioquímicas que requieren auditoría médica.
Código | Detalle |
---|---|
66.01.40 | CARIOTIPO , MAPA CROMOSOMICO |
66.06.20 | LIQUIDO DE PUNCION, FCO-QCO - CITOLOGICO |
66.11.42 | PREPARACION DE SANGRE A TRANSFUNDIR (MODULO T |
66.25.47 | ALFA GALACTOSIDASA (FABRY) |
66.25.59 | ALFA L IDURONIDASA |
66.26.20 | AMINOACIDOS - LCR (CROMATOGRAFIA CUANTITATIV |
66.26.23 | AMINOACIDOS - SERICO (CROMATOGRAFIA CUANTITAT |
66.26.24 | AMINOACIDOS, SSPF (CUANTITATIVO) |
66.26.27 | AMINOACIDOS - URINARIOS (CROMATOGRAFIA CUANT |
66.26.88 | ANFETAMINAS / METANFETAMINAS, CONFIRMATORIO |
66.27.00 | ANGELMAN, SINDROME DE |
66.28.20 | ARILSULTASA A - EN LEUCOSITOS |
66.28.63 | BANDAS OLIGOCLONALES, EN L.C.R. |
66.28.73 | BANDEO G |
66.28.88 | BARBITURATOS, CONFIRMATORIO. |
66.30.34 | BETA GALACTOSIDASA |
66.30.42 | BETA GLUCOCEREBROSIDASA |
66.31.45 | BRCA 1/2 SCREENING |
66.33.50 | CANNABINOIDES, GC-MS - CONFIRMATORIO (MARIHUA |
66.34.27 | CARIOTIPO, ALTA RESOLUCION (ALTA SENSIBILIDAD |
66.34.30 | CARIOTIPO, CON BANDEO GTG |
66.34.35 | CARIOTIPO - LIQUIDO ANMIOTICO |
66.34.40 | CARIOTIPO - MATERIAL DE ABORTO |
66.34.43 | CARIOTIPO - MEDULA OSEA |
66.34.46 | CARIOTIPO - VELLOSIDADES CORIONICAS |
66.34.61 | CARNITINA, LIBRE Y TOTAL |
66.34.63 | CARNITINA, LIBRE Y TOTAL - URINARIO |
66.35.85 | CHITOTRIOSIDASA - SANGUINEA. |
66.35.86 | CHITOTRIOSIDASA - SANGUINEA/SOPORTE-PAPEL (FU |
66.36.49 | CHLAMYDIA TRACHOMATIS, AG. PCR |
66.37.20 | CITOMEGALOVIRUS, DNA CARGA VIRAL (CMV-DNA CAR |
66.37.22 | CITOMEGALOVIRUS, DNA POR PCR (CMV-DNA POR PCR |
66.37.25 | CITOMEGALOVIRUS, LCR CUANTITATIVO POR PCR (CM |
66.38.28 | COCAINA, GC-MS |
66.38.80 | COCLEARES, AC. ANTI- (ANTI- P68 KDA) (WESTERN |
66.39.05 | COFACTOR DE RISTOCETINA |
66.39.74 | COREA DE HUNTINGTON POR PCR |
66.41.50 | CROMOSOMA FILADELFIA - PCR - CITOGENETICO LMC |
66.41.55 | CROMOSOMA X, FRAGILIDAD - PCR |
66.41.60 | CROMOSOMA X, FISH |
66.41.65 | CROMOSOMA Y, DELECCIONES DEL |
66.41.87 | CROSS MATCH, AUTOLOGO - CITOM. DE FLUJO |
66.41.90 | CROSS MATCH, AUTOLOGO - LINFOTOXICIDAD. |
66.41.96 | CROSS MATCH, CONTRA PANEL |
66.42.04 | CROSS MATCH, DONANTE - CITOM. DE FLUJO |
66.42.13 | CROSS MATCH, DONANTE - LINFOTOXICIDAD. |
66.42.21 | CROSS MATCH, DTT |
66.42.30 | CROSS MATCH, MATRIMONIAL - CITOMETRIA DE FLUJ |
66.42.40 | CROSS MATCH, PACIENTE HIPERSENSIBILIZADO |
66.43.69 | DENGUE - PCR |
66.46.91 | ENTEROVIRUS, PCR |
66.47.17 | EPSTEIN BARR, DNA CARGA VIRAL - PCR |
66.52.47 | FIBROSIS QUISTICA, 19 MUTACIONES - PCR |
66.52.55 | FIBROSIS QUISTICA, 29 MUTACIONES - PCR |
66.52.73 | FILIACION ESTUDIO DNA EXTRA CADA UNO |
66.52.81 | FILIACION ESTUDIO DNA (HASTA 3 PERSONAS) |
66.52.90 | FISH WILLIAMS |
66.55.29 | GANGLIOSIDO ASIALO GM1, AC. ANTI- |
66.55.33 | GANGLIOSIDO GD 1B, AC. ANTI- |
66.55.37 | GANGLIOSIDO GM1 A, AC. (IGG + IGM) ANTI- |
66.55.41 | GANGLIOSIDO QUADROSIALO, GQ1B AC. IGG |
66.55.46 | GANGLIOSIDOS PANEL, AC. (IGG + IGM) GM1 ASIAL |
66.56.49 | GLUCOCEREBROSIDASA |
66.56.74 | GQ1B AC. IGG |
66.57.94 | HEMOCROMATOSIS, MUTACION C282Y Y H63D |
66.58.37 | HEMOGLOBINURIA PAROXISTICA NOCTURNA X CF |
66.59.14 | HEPATITIS B, CARGA VIRAL (AMPLICOR) |
66.59.31 | HEPATITIS B, DNA VIRAL (HBV-DNA) (PCR - CUALI |
66.59.56 | HEPATITIS C, CARGA VIRAL - PCR |
66.59.65 | HEPATITIS C, CENOTIPIFICACION - PCR |
66.59.73 | HEPATITIS C, LIA |
66.59.82 | HEPATITIS C, RNA CUALITATIVO - PCR |
66.60.37 | HERPES SIMPLEX, 1 / 2 - (PCR) |
66.61.53 | HEXOSAMINIDASA TOTAL, A Y B |
66.62.81 | HIV, RESISTENCIA A ANTIRETROVIRALES |
66.62.90 | HIV, RNA CUANTITATIVO |
66.63.00 | HLA A, MOLECULAR |
66.63.03 | HLA B, MOLECULAR |
66.63.07 | HLA A,B MOLECULAR |
66.63.32 | HLA B 27 MOLECULAR |
66.63.41 | HLA C MOLECULAR |
66.64.01 | HLA DQ MOLECULAR |
66.64.09 | HLA DR CITOMETRIA FLUJO |
66.64.26 | HLA DR MOLECULAR |
66.65.33 | HTLV-1 PCR |
66.66.57 | IGG - INMUNOGLOBULINA G, SUBCLASES (MODULO |
66.67.25 | INFLUENZA A, ANTIGENO (AG.) |
66.67.30 | INFLUENZA A, ANTIGENOS (AGS.) SUBTIPOS- MATER |
66.67.34 | INFLUENZA A, AC. IGG ANTI- |
66.67.42 | INFLUENZA A, AC. IGM ANTI- |
66.67.51 | INFLUENZA B, AC. IGG ANTI- |
66.67.60 | INFLUENZA B, AC. IGM ANTI- |
66.67.68 | INFLUENZA B, ANTIGENO (AG.) |
66.67.88 | INHIBINA B - SERICA |
66.68.45 | INMUNOFENOTIPO-SUBPOBLACIONES LINFOCITAR |
66.68.48 | INMUNOFIJACION - LCR |
66.68.50 | INMUNOFIJACION - SERICA |
66.68.52 | INMUNOFIJACION - URINARIA |
66.68.71 | INTERFERON GAMMA |
66.68.79 | INTERLEUQUINA C/U |
66.70.30 | LEUCINAS AGUDAS, FENOTIPIFICACION |
66.73.15 | MAG-SGPG, AC. IGM |
66.76.69 | MYCOBACTERIUM TUBERCULOSIS, DNA - PCR |
66.77.94 | NEUMOCOCO, AC. ANTI- |
66.78.82 | OPIACEOS - CONFIRMATORIO |
66.79.47 | OVARIO, AC. ANTI- |
66.79.90 | PAI 4G/5G |
66.79.99 | PANEL HEPATICO INMUNOLOGICO |
66.80.09 | PAPILOMA VIRUS HUMANO - HPV (CARGA VIRAL) |
66.80.11 | PAPILOMA VIRUS HUMANO - HPV (GENOTIPIFICACION |
66.80.18 | PAPP - A SE REALIZA JUNTO A BETA LIBRE HCG (3 |
66.85.54 | PRO BNP - PEPTIDO NATRIURETICO, HORMONA. |
66.86.06 | PROTEINA BASICA DE MIELINA |
66.87.94 | REARREGLO DEL TCR (CITROMETRÞA DE FLUJO) |
66.88.53 | RI (ANNA-2), AC. ANTI- (NEURONAL NUCLEAR-2) |
66.91.01 | SINDROMES LINFOPROLIF. CRONICOS - FENOTI |
66.91.05 | SITRULIMUS, DROGA CITOSTATICA (PARA TRASPLANT |
66.92.04 | SUCCINIL PURINAS |
66.93.14 | TEST DE DESENSIBILIZACION TESTICULAR |
66.95.91 | TOXOPLASMOSIS, PCR |
66.96.33 | TRANSLOCACION (9;22) REAR. BCR/ABL LMC |
66.96.34 | TRANSLOCACION (9;22) REAR. BCR/ABL LLA |
66.96.35 | TRANSLOCACION 14;18 |
66.96.36 | TRANSLOCACION MLL/AF4, T (4,11) |
66.96.37 | TRANSLOCACION PML/RAR, T (15,17) |
66.96.38 | TRASLOCACION T (8;21) - AML 1/ETO |
66.96.39 | TRASLOCACION TEL /AML T(12;21) |
66.96.65 | TRIPLE TEST |
66.97.16 | TROMBOFILIA, PANEL |
66.98.34 | VARICELA ZOSTER, DNA POR PCR |
66.99.60 | YO (PCA-1), AC. ANTI- |
66.99.73 | ZAP 70 |